Clinical Trial Update: Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

View source ↗

Summary

A completed safety surveillance study of the hepatitis C drug combination asunaprevir and daclatasvir in Japanese patients with chronic hepatitis C, detailing o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• Daclatasvir (daclatasvir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis C | Status: COMPLETED